Gland Pharma consolidated net profit declines 34.64% in the June 2022 quarter

20 Jul 2022 , 05:47 PM

Net profit of Gland Pharma declined 34.64% to Rs 229.17 crore in the quarter ended June 2022 as against Rs 350.65 crore during the previous quarter ended June 2021. Sales declined 25.74% to Rs 856.90 crore in the quarter ended June 2022 as against Rs 1153.90 crore during the previous quarter ended June 2021.

Particulars	Quarter Ended
?	Jun. 2022	Jun. 2021	% Var.
Sales	856.90	1153.90	-26
OPM %	31.50	37.81	–
PBDT	343.41	497.12	-31
PBT	308.50	471.84	-35
NP	229.17	350.65	-35

Powered by Capital Market – Live News